Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ABT-806 |
Synonyms | |
Therapy Description |
Depatuxizumab (ABT-806) is a monoclonal antibody that binds to the epitope of EGFR vIII and amplified EGFR, but not wild-type EGFR, and may result in anti-tumor activity (PMID: 25731184, PMID: 29449271). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ABT-806 | Depatuxizumab | EGFR Antibody 56 | Depatuxizumab (ABT-806) is a monoclonal antibody that binds to the epitope of EGFR vIII and amplified EGFR, but not wild-type EGFR, and may result in anti-tumor activity (PMID: 25731184, PMID: 29449271). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|